Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.5M Buy
+1,508,518
New +$8.91M 0.01% 1264
2024
Q4
Sell
-8,127
Closed -$132K 2171
2024
Q3
$132K Buy
+8,127
New +$114K ﹤0.01% 1843
2024
Q2
Sell
-196,200
Closed -$2.75M 2009
2024
Q1
$2.75M Buy
+196,200
New +$2.55M 0.01% 1162
2023
Q2
Sell
-2,191
Closed -$18.5K 2331
2023
Q1
$18.5K Buy
+2,191
New +$19.8K ﹤0.01% 1981
2022
Q2
Sell
-309,800
Closed -$3.48M 1454
2022
Q1
$3.48M Sell
309,800
-800
-0.3% -$6.82K 0.01% 777
2021
Q4
$2.02M Buy
+310,600
New +$2.13M 0.01% 820
2021
Q2
Sell
-79,600
Closed -$1.03M 1023
2021
Q1
$1.03M Buy
+79,600
New +$734K ﹤0.01% 799
2020
Q1
Sell
-207,200
Closed -$2.52M 861
2019
Q4
$2.52M Buy
+207,200
New +$2.92M 0.01% 601
2019
Q3
Sell
-285,000
Closed -$4.17M 1209
2019
Q2
$4.17M Buy
+285,000
New +$5.65M 0.02% 547
2019
Q1
Sell
-389,985
Closed -$4.64M 1075
2018
Q4
$4.64M Sell
389,985
-367,972
-49% -$5.25M 0.02% 570
2018
Q3
$14.1M Buy
+757,957
New +$16.4M 0.06% 384

Other funds holding EOLS

Steven Cohen's EOLS Position: Q2 2026 in Review

Steven Cohen opened a new position in Evolus (EOLS) in Q2 2026: 1,508,518 shares worth $10.5M. The stake represents 0.01% of the portfolio and ranks #1264 among its holdings. This is a return to the name: Steven Cohen previously reported a position in EOLS as recently as Q3 2024.

Steven Cohen first reported a position in EOLS in Q3 2018 and has held it in 11 quarters since. The position peaked at $14.1M in Q3 2018. 157 funds tracked by Wall St. Rank hold EOLS as of Q2 2026.

  • Steven Cohen held 1,508,518 shares of Evolus worth $10.5M as of Q2 2026.
  • Evolus was a new Steven Cohen position in Q2 2026.
  • Evolus made up 0.01% of Steven Cohen's portfolio in Q2 2026, its #1264 holding.
  • Steven Cohen first reported a position in Evolus in Q3 2018 and has held it in 11 quarters since.
  • Steven Cohen's Evolus position peaked at $14.1M in Q3 2018.
  • 157 funds tracked by Wall St. Rank held Evolus as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.